StockWatch
·
HomeLiveReports
Biotechnology: Pharmaceutical Preparations
OtherSep 21, 2026, 01:23 PM

Dr. Reddy's Laboratories Files Form 6-K Report with Intimation Exhibit

AI Summary

This filing is a Form 6-K report for Dr. Reddy's Laboratories Limited. It indicates that the company files annual reports under Form 20-F. The report includes Exhibit 99.1, which is an intimation dated September 21, 2026. No other specific business or financial information is detailed in the provided text.

View SEC Filing
RDY
Biotechnology: Pharmaceutical Preparations
DR REDDYS LABORATORIES LTD

Price Impact

More from RDY

Management ChangeAug 13, 9:56 AM

Dr. Reddy's CEO of API & Services Deepak Sapra Resigns

USFDAAug 3, 6:31 AM

Dr. Reddy's Receives U.S. FDA Approval for Rituximab Biosimilar

OtherJul 29, 2:06 PM

DR. REDDY’S LABORATORIES Files Intimation

More in Other

LUSep 18, 8:06 AM

Lufax Holding Ltd Files Form 6-K for September 2026

AGMHSep 18, 8:06 AM

AGM Group Holdings Inc. Files Form 6-K with Share Purchase Agreement Exhibit

ATHESep 16, 6:08 AM

Alterity Therapeutics Files Form 6-K for September 2026